DELTA-9-TETRAHYDROCANNABINOL (THC)

Clinical trials for DELTA-9-TETRAHYDROCANNABINOL (THC) explained in plain language.

Never miss a new study

Get alerted when new DELTA-9-TETRAHYDROCANNABINOL (THC) trials appear

Sign up with your email to follow new studies for DELTA-9-TETRAHYDROCANNABINOL (THC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Cannabis compound tested as a way to soften painful memories

Symptom relief Completed

This early-phase trial investigates whether delta-9-tetrahydrocannabinol (THC), the main psychoactive compound in cannabis, can reduce the emotional and physical responses triggered by recalling stressful experiences. Healthy adults aged 18–35 with some prior cannabis use will re…

Matched conditions: DELTA-9-TETRAHYDROCANNABINOL (THC)

Phase: EARLY_PHASE1 • Sponsor: University of Chicago • Aim: Symptom relief

Last updated Jul 11, 2026 00:00 UTC

DELTA-9-TETRAHYDROCANNABINOL (THC)

Get alerted when new DELTA-9-TETRAHYDROCANNABINOL (THC) trials appear

Cannabis compound tested as a way to soften painful memories